Hims & Hers Health Statistics
Share Statistics
Hims & Hers Health has 210.10M shares outstanding. The number of shares has increased by 2.68% in one year.
| Shares Outstanding | 210.10M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 0.8% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 177.60M |
| Failed to Deliver (FTD) Shares | 25.35K |
| FTD / Avg. Volume | 0.16% |
Short Selling Information
The latest short interest is 33.84M, so 16.11% of the outstanding shares have been sold short.
| Short Interest | 33.84M |
| Short % of Shares Out | 16.11% |
| Short % of Float | 19.09% |
| Short Ratio (days to cover) | 2.66 |
Valuation Ratios
The PE ratio is -79.13 and the forward PE ratio is 58.02.
| PE Ratio | -79.13 |
| Forward PE | 58.02 |
| PS Ratio | 2.14 |
| Forward PS | 3.3 |
| PB Ratio | 5.42 |
| P/FCF Ratio | 39.65 |
| PEG Ratio | n/a |
Enterprise Valuation
Hims & Hers Health Inc. has an Enterprise Value (EV) of 1.78B.
| EV / Earnings | -75.45 |
| EV / Sales | 2.04 |
| EV / EBITDA | -89.1 |
| EV / EBIT | -60.31 |
| EV / FCF | 37.8 |
Financial Position
The company has a current ratio of 3, with a Debt / Equity ratio of 0.
| Current Ratio | 3 |
| Quick Ratio | 2.74 |
| Debt / Equity | 0 |
| Total Debt / Capitalization | 0.37 |
| Cash Flow / Debt | 57.36 |
| Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is -0.07% and return on capital (ROIC) is -9.08%.
| Return on Equity (ROE) | -0.07% |
| Return on Assets (ROA) | -0.05% |
| Return on Capital (ROIC) | -9.08% |
| Revenue Per Employee | 833.65K |
| Profits Per Employee | -22.51K |
| Employee Count | 1.05K |
| Asset Turnover | 1.98 |
| Inventory Turnover | 6.99 |
Taxes
| Income Tax | 1.98M |
| Effective Tax Rate | -0.09 |
Stock Price Statistics
The stock price has increased by 253.85% in the last 52 weeks. The beta is 1.06, so Hims & Hers Health 's price volatility has been higher than the market average.
| Beta | 1.06 |
| 52-Week Price Change | 253.85% |
| 50-Day Moving Average | 24.27 |
| 200-Day Moving Average | 18.81 |
| Relative Strength Index (RSI) | 54.89 |
| Average Volume (20 Days) | 15.93M |
Income Statement
In the last 12 months, Hims & Hers Health had revenue of $872.00M and earned -$23.55M in profits. Earnings per share was $-0.11.
| Revenue | 872.00M |
| Gross Profit | 714.95M |
| Operating Income | -29.45M |
| Net Income | -23.55M |
| EBITDA | -19.94M |
| EBIT | -29.45M |
| Earnings Per Share (EPS) | -0.11 |
Balance Sheet
The company has $96.66M in cash and $9.95M in debt, giving a net cash position of $86.72M.
| Cash & Cash Equivalents | 96.66M |
| Total Debt | 9.95M |
| Net Cash | 86.72M |
| Retained Earnings | -368.18M |
| Total Assets | 602.26M |
| Working Capital | 173.73M |
Cash Flow
In the last 12 months, operating cash flow was $73.48M and capital expenditures -$26.49M, giving a free cash flow of $46.99M.
| Operating Cash Flow | 73.48M |
| Capital Expenditures | -26.49M |
| Free Cash Flow | 46.99M |
| FCF Per Share | 0.22 |
Margins
Gross margin is 81.99%, with operating and profit margins of -3.38% and -2.7%.
| Gross Margin | 81.99% |
| Operating Margin | -3.38% |
| Pretax Margin | -2.47% |
| Profit Margin | -2.7% |
| EBITDA Margin | -2.29% |
| EBIT Margin | -3.38% |
| FCF Margin | 5.39% |
Dividends & Yields
HIMS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -0.37% |
| FCF Yield | 0.75% |
Analyst Forecast
The average price target for HIMS is $21, which is -29.8% lower than the current price. The consensus rating is "Hold".
| Price Target | $21 |
| Price Target Difference | -29.8% |
| Analyst Consensus | Hold |
| Analyst Count | 12 |
Scores
| Altman Z-Score | 25.4 |
| Piotroski F-Score | 5 |